|
1
|
Lee WM: Acute liver failure. Semin Respir
Crit Care Med. 33:36–45. 2012. View Article : Google Scholar
|
|
2
|
Mas A and Rodés J: Fulminant hepatic
failure. Lancet. 349:1081–1085. 1997. View Article : Google Scholar
|
|
3
|
Macnaughtan J and Thomas H: Liver failure
at the front door. Clin Med. 10:73–78. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Neuberger J: Prediction of survival for
patients with fulminant hepatic failure. Hepatology. 41:19–22.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bernal W, Auzinger G, Dhawan A and Wendon
J: Acute liver failure. Lancet. 376:190–201. 2010. View Article : Google Scholar
|
|
6
|
Tanaka Y, Takahashi K, Orito E, et al:
Molecular tracing of Japan-indigenous hepatitis E viruses. J Gen
Virol. 87:949–954. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li TC, Chijiwa K, Sera N, et al: Hepatitis
E virus transmission from wild boar meat. Emerg Infect Dis.
11:1958–1960. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chau TN, Lai ST, Tse C, et al:
Epidemiology and clinical features of sporadic hepatitis E as
compared with hepatitis A. Am J Gastroenterol. 101:292–296. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Togo S, Kubota T, Matsuo K, et al:
Mechanism of liver failure after hepatectomy. Nihon Geka Gakkai
Zasshi. 105:658–663. 2004.(In Japanese).
|
|
10
|
Pathil A, Warth A, Chamulitrat W and
Stremmel W: The synthetic bile acid-phospholipid conjugate
ursodeoxycholyl lysophosphatidylethanolamide suppresses
TNFα-induced liver injury. J Hepatol. 54:674–684. 2011.PubMed/NCBI
|
|
11
|
McCloskey P, Tootle R, Selden C, Larsen F,
Roberts E and Hodgson HJ: Modulation of hepatocyte function in an
immortalized human hepatocyte cell line following exposure to
liver-failure plasma. Artif Organs. 26:340–348. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rolando N, Wade J, Davalos M, Wendon J,
Philpott-Howard J and Williams R: The systemic inflammatory
response syndrome in acute liver failure. Hepatology. 32:734–739.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rolando N, Harvey F, Brahm J, et al:
Prospective study of bacterial infection in acute liver failure: an
analysis of fifty patients. Hepatology. 11:49–53. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vaquero J, Polson J, Chung C, et al:
Infection and the progression of hepatic encephalopathy in acute
liver failure. Gastroenterology. 125:755–764. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kamimoto M, Mizuno S and Nakamura T:
Reciprocal regulation of IL-6 and IL-10 balance by HGF via
recruitment of heme oxygenase-1 in macrophages for attenuation of
liver injury in a mouse model of endotoxemia. Int J Mol Med.
24:161–170. 2009.PubMed/NCBI
|
|
16
|
McAvoy EF, McDonald B, Parsons SA, Wong
CH, Landmann R and Kubes P: The role of CD14 in neutrophil
recruitment within the liver microcirculation during endotoxemia. J
Immunol. 186:2592–2601. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Raulf-Heimsoth M, Liebers V and Brüning T:
Mechanism of endotoxin action and pattern of diseases. Gefahrstoffe
Reinhaltung Der Luft. 67:351–353. 2007.(In German).
|
|
18
|
Li T, Hu J, Thomas JA and Li L:
Differential induction of apoptosis by LPS and taxol in monocytic
cells. Mol Immunol. 42:1049–1055. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Muto Y, Nouri-Aria KT, Meager A, Alexander
GJ, Eddleston AL and Williams R: Enhanced tumour necrosis factor
and interleukin-1 in fulminant hepatic failure. Lancet. 2:72–74.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jalan R, Olde Damink S, Hayes PC, Deutz
NEP and Lee A: Pathogenesis of intracranial hypertension in acute
liver failure: inflammation, ammonia and cerebral blood flow. J
Hepatol. 41:613–620. 2004. View Article : Google Scholar
|
|
21
|
Han DW: Intestinal endotoxemia as a
pathogenetic mechanism in liver failure. World J Gastroenterol.
8:961–965. 2002.PubMed/NCBI
|
|
22
|
Warren HS, Amato SF, Fitting C, et al:
Assessment of ability of murine and human anti-lipid A monoclonal
antibodies to bind and neutralize lipopolysaccharide. J Exp Med.
177:89–97. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Newsome PN, Tsiaoussis J, Masson S, et al:
Serum from patients with fulminant hepatic failure causes
hepatocyte detachment and apoptosis by a beta(1)-integrin pathway.
Hepatology. 40:636–645. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Du WB, Pan XP, Yu XP, et al: Effects of
plasma from patients with acute on chronic liver failure on
function of cytochrome P450 in immortalized human hepatocytes.
Hepatobiliary Pancreat Dis Int. 9:611–614. 2010.PubMed/NCBI
|
|
25
|
Chen M, Zhou J, Li H, Chen A, Zhang Z and
Tian D: Effects of endotoxin on liver Smac apoptosis channel. J
Huazhong Univ Sci Technolog Med Sci. 28:660–664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nie B, Park HM, Kazantzis M, et al:
Specific bile acids inhibit hepatic fatty acid uptake in mice.
Hepatology. 56:1300–1310. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li T, Jahan A and Chiang JY: Bile acids
and cytokines inhibit the human cholesterol 7 alpha-hydroxylase
gene via the JNK/c-Jun pathway in human liver cells. Hepatology.
43:1202–1210. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Reinehr R and Häussinger D: Inhibition of
bile salt-induced apoptosis by cyclic AMP involves serine/threonine
phosphorylation of CD95. Gastroenterology. 126:249–262. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Karimian G, Buist-Homan M, Mikus B,
Henning RH, Faber KN and Moshage H: Angiotensin II protects primary
rat hepatocytes against bile salt-induced apoptosis. PLoS One.
7:e526472012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mayorga M, Iborra A, Estany S and Martínez
P: Protective effect of vitamin E in an animal model of LPS-induced
inflammation. Am J Reprod Immunol. 52:356–361. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McGhee JR, Kiyono H, Michalek SM, Babb JL,
Rosenstreich DL and Mergenhagen SE: Lipopolysaccharide (LPS)
regulation of the immune response: T lymphocytes from normal mice
suppress mitogenic and immunogenic responses to LPS. J Immunol.
124:1603–1611. 1980.PubMed/NCBI
|
|
32
|
Hitchcock PJ, Leive L, Mäkelä PH,
Rietschel ET, Strittmatter W and Morrison DC: Lipopolysaccharide
nomenclature - past, present, and future. J Bacteriol. 166:699–705.
1986.PubMed/NCBI
|
|
33
|
Lachman E, Pitsoe SB and Gaffin SL:
Anti-lipopolysaccharide immunotherapy in management of septic shock
of obstetric and gynaecological origin. Lancet. 1:981–983. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ziegler EJ, Fisher CJ Jr, Sprung CL, et
al; The HA-1A Sepsis Study Group. Treatment of gram-negative
bacteremia and septic shock with HA-1A human monoclonal antibody
against endotoxin. A randomized, double-blind, placebo-controlled
trial. N Engl J Med. 324:429–436. 1991. View Article : Google Scholar
|
|
35
|
Recknagel P, Gonnert FA, Halilbasic E, et
al: Mechanisms and functional consequences of liver failure
substantially differ between endotoxaemia and faecal peritonitis in
rats. Liver Int. 33:283–293. 2013. View Article : Google Scholar : PubMed/NCBI
|
